|Articles|July 15, 2002
Microelectronic device continues to show promise
Fort Lauderdale, FL-A subretinal micro-photodiode-based silicon chip (Artificial Silicon Retina, ASR) implanted in patients with retinitis pigmentosa (RP) appears to be safe while showing continued improvement in both subjective and objective measures of visual function, said Alan Y. Chow, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology here.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5
























